Early Biosimilar Development: A Model for Expeditious Progress to a Phase 3 Trial
Feature ArticlesRaymond Huml, MS, DVM, RAC • Nigel Rulewski, MD • Kamali Chance, MPH, PhD, RAC • Doris Weilert • J. Rick Turner
Feature ArticlesRaymond Huml, MS, DVM, RAC • Nigel Rulewski, MD • Kamali Chance, MPH, PhD, RAC • Doris Weilert • J. Rick Turner